Lai Quintin J
Known title: VP Corp Development & StrategyCIK: 0001744326
Associated companies
Transaction History
| WST | ▲ Buy | Grant | 375 | $0 | 2/20/2024 | View on chart |
| WST | ▼ Sell | Open Market | 1,741 | $690K | 8/11/2023 | View on chart |
| WST | ▲ Buy | Option Exercise | 8,772 | $786K | 8/11/2023 | View on chart |
| WST | ▲ Buy | Option Exercise | 7,140 | $732K | 8/11/2023 | View on chart |
| WST | ▲ Buy | Option Exercise | 453 | $167K | 8/11/2023 | View on chart |
| WST | ▼ Sell | Open Market | 10,725 | $4.2M | 8/11/2023 | View on chart |
| WST | ▼ Sell | Open Market | 8,635 | $3.4M | 8/11/2023 | View on chart |
| WST | ▲ Buy | Option Exercise | 3,348 | $580K | 8/11/2023 | View on chart |
| WST | ▲ Buy | Option Exercise | 1,388 | $381K | 8/11/2023 | View on chart |
| WST | ▲ Buy | Grant | 1,134 | $348K | 2/21/2023 | View on chart |
| WST | ▼ Sell | Open Market | 1,254 | $464K | 3/14/2022 | View on chart |
| WST | ▼ Sell | Open Market | 446 | $165K | 3/14/2022 | View on chart |
| WST | ▼ Sell | Open Market | 600 | $223K | 3/14/2022 | View on chart |
| WST | ▼ Sell | Open Market | 2,940 | $1.1M | 3/14/2022 | View on chart |
| WST | ▼ Sell | Open Market | 200 | $75K | 3/14/2022 | View on chart |
| WST | ▲ Buy | Option Exercise | 2,440 | $230K | 3/14/2022 | View on chart |
| WST | ▲ Buy | Option Exercise | 5,576 | $465K | 3/14/2022 | View on chart |
| WST | ▼ Sell | Open Market | 1,271 | $467K | 3/14/2022 | View on chart |
| WST | ▼ Sell | Open Market | 405 | $149K | 3/14/2022 | View on chart |
| WST | ▼ Sell | Open Market | 900 | $336K | 3/14/2022 | View on chart |
| WST | ▲ Buy | Grant | 3,138 | $1.2M | 2/22/2022 | View on chart |
| WST | ▲ Buy | Option Exercise | 8,672 | $517K | 9/10/2021 | View on chart |
| WST | ▲ Buy | Option Exercise | 1,000 | $73K | 9/10/2021 | View on chart |
| WST | ▼ Sell | Open Market | 5,072 | $2.3M | 9/10/2021 | View on chart |
| WST | ▼ Sell | Open Market | 3,100 | $1.4M | 9/10/2021 | View on chart |
| WST | ▼ Sell | Open Market | 1,500 | $694K | 9/10/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
West Pharmaceutical Services noted in analyst upgrade and market rally
West Pharmaceutical Services has risen about 36% year-to-date, drawing attention in recent market round-ups. TD Cowen kept its positive stance and lifted its price target to $420, citing the company's performance. The stock also appeared in CNBC’s final‑trade segment and in a dividend‑growth stock list, highlighting investor interest.
West Pharmaceutical Services noted in analyst upgrade and market rally. West Pharmaceutical Services has risen about 36% year-to-date, drawing attention in recent market round-ups. TD Cowen kept its positive stance and lifted its price target to $420, citing the company's performance. The stock also appeared in CNBC’s final‑trade segment and in a dividend‑growth stock list, highlighting investor interest.